Trending...
- Author Explodes Damning Myths about Hunger in America
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
SAN DIEGO, May 11, 2021 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced that Randall Kaye, Chief Medical Officer, will present at the 21st Annual Pain Therapeutics Conference. The conference takes place virtually May 10-11th. Presentations will be available for registered attendees via the conference website.
About Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. is a privately held, clinical-stage, biotechnology company focused on the treatment of neuromuscular conditions, including acute, painful muscle spasms of the back. The company was founded in 2013 and is based in San Diego. Neurana's lead development compound is tolperisone, a novel, non-opioid, non-drowsy, non-cognitive impairing treatment, which the company is developing for the large population of patients who experience muscle spasms. In May 2018, Neurana completed a $60 million Series A financing led by Sofinnova Ventures with participation from Longitude Capital, New Leaf Venture Partners and H.I.G. BioHealth Partners to fund the clinical development of tolperisone. For additional information, please visit www.neuranapharma.com.
More on The Californer
SOURCE Neurana Pharmaceuticals, Inc.
Related Links
http://www.neuranapharma.com
About Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. is a privately held, clinical-stage, biotechnology company focused on the treatment of neuromuscular conditions, including acute, painful muscle spasms of the back. The company was founded in 2013 and is based in San Diego. Neurana's lead development compound is tolperisone, a novel, non-opioid, non-drowsy, non-cognitive impairing treatment, which the company is developing for the large population of patients who experience muscle spasms. In May 2018, Neurana completed a $60 million Series A financing led by Sofinnova Ventures with participation from Longitude Capital, New Leaf Venture Partners and H.I.G. BioHealth Partners to fund the clinical development of tolperisone. For additional information, please visit www.neuranapharma.com.
More on The Californer
- VCCCD Board Elects Leadership for New Year
- City of Long Beach Preparing for Upcoming Weather Event, Encourages Residents to Take Precautions
- Easiest Self Wash in Northridge CA
- $8 Car Wash in Northridge CA Will Save You Money
- Core Level Health Now Available in Irvine, CA: Daily Multivitamin for Energy + Immune Support
SOURCE Neurana Pharmaceuticals, Inc.
Related Links
http://www.neuranapharma.com
Filed Under: Business
0 Comments
Latest on The Californer
- Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
- PawRobo™: First Truly Robotic Canned Cat Food Feeder – No Fridge or Ice Packs
- Holiday-Ready Bracelets That Look Luxe Without the Price Tag
- "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
- National Olympic Committee of Denmark to Establish Base of Operations, Team House in Long Beach for 2028 Olympic Games
- Deckmaster Fine Decks Inc. Earns Diamond Certified® Recognition
- The International Songwriters Day Song Contest Launches!
- 2025 Aquila Polonica Article Prize Winner Announced
- The Womens Freedom Song Contest Launches!
- Ventura Chamber of Commerce Names Cumulus Media VP Sommer Frisk "Shining Star of the Year"
- City of Long Beach to Host Second Business Networking Event Along Santa Fe Avenue Corridor
- New Year's Business Resolution: "Sell Everything and Sell it NOW!"
- Beycome Closes $2.5M Seed Round Led by InsurTech Fund
- IPoly Seniors Tackle Local Infrastructure Challenges Through Civic Action Projects
- Long Beach Health Department Urges Community to Avoid Kratom and 7-OH Products Amid Rising Overdose Risk
- IPoly High School Earns 'All Blue' State Achievement Distinction, Receives Golden Bell Award
- Sonet.io Unveils Safer Enterprise Architecture for AI Agents Without Internet Exposure
- New Year's Business Resolution Number One: Start using this very effective Marketing Math Today!
- Tru by Hilton Columbia South Opens to Guests
- Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes